Valtedseq

Gaithersburg, US · 1 known investors

Valted Seq develops an end-to-end platform powered by robotics and AI for single-cell analysis of brain tissue, enabling biomarker and therapeutic target discovery for neurodegenerative diseases. The company operates a large single-cell genomics database supporting research into conditions like Alzheimer's and Parkinson's disease.

AI & Machine LearningBiotechMedical Devices